ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМПymj-2406Research ArticleКЛИНИЧЕСКАЯ ГЕНЕТИКА И ДИАГНОСТИКА НАСЛЕДСТВЕННЫХ ЗАБОЛЕВАНИЙCLINICAL GENETICS AND DIAGNOSTICS OF HEREDITARY DISEASESНеобходимость ранней диагностики и адекватного лечения больных муковисцидозом в РоссииNecessity of early diagnostics and adequate treatment of patients with cystic fibrosis in RussiaКапрановН. И.KapranovN. I.

Капранов Николай Иванович – д.м.н., проф., засл. деятель науки РФ, руковод. научно-клинического отдела

г. Москва

КаширскаяН. Ю.KashirskajaN. J.

Каширская Наталья Юрьевна – д.м.н., проф., вед.н.с.

ШерманВ. Д.ShermanV. D.

Шерман Виктория Давидовна – к.м.н., врач-педиатр;

зав. отделением поликлиники

Медико-генетический научный центр РАМНRussian FederationМГ НЦ РАМНRussian FederationМГ НЦ РАМН; ДГКБ №13 им. Н.Ф. ФилатоваRussian Federation200926102025024549Copyright © Капранов Н.И., Каширская Н.Ю., Шерман В.Д., 20252025Капранов Н.И., Каширская Н.Ю., Шерман В.Д.Kapranov N.I., Kashirskaja N.J., Sherman V.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/2406

.

ReferencesКапранов Н.И. Муковисцидоз – современное состояние проблемы//Пульмонология 2006, с. 3-11 (приложение по муковисцидозу).Капранов Н.И. Муковисцидоз – современное состояние проблемы//Пульмонология 2006, с. 3-11 (приложение по муковисцидозу).Муковисцидоз. Современные достижения и актуальные проблемы. Метод. рекомендации. Издание второе (первое 2001) переработанное и дополненное / Капранов Н.И., Каширская Н.Ю., Воронкова А.Ю. и др. М.: 2005. – 109с.;Муковисцидоз. Современные достижения и актуальные проблемы. Метод. рекомендации. Издание второе (первое 2001) переработанное и дополненное / Капранов Н.И., Каширская Н.Ю., Воронкова А.Ю. и др. М.: 2005. – 109с.;Cystic Fibrosis Trust. UK CF Database Annual Data Report 2003. Bromley, UK, 2005.Cystic Fibrosis Trust. UK CF Database Annual Data Report 2003. Bromley, UK, 2005.Dodge JA, Lewis PA, Stanton M et al. Cystic fibrosis mortality and survival in the United Kingdom, 1947 to 2003// Eur Respir J. 2006 Dec 20.Dodge JA, Lewis PA, Stanton M et al. Cystic fibrosis mortality and survival in the United Kingdom, 1947 to 2003// Eur Respir J. 2006 Dec 20.Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the new-born. Lancet 1979;1(8114):472-4.Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the new-born. Lancet 1979;1(8114):472-4.Rock MJ, Mishler EH, Farrell PM et al. Newborn screening for cystic fibrosis is complicated by agerelated decline in immunoreactive trypsinogen levels. Pediatrics 1990;85(6):1001-7.Rock MJ, Mishler EH, Farrell PM et al. Newborn screening for cystic fibrosis is complicated by agerelated decline in immunoreactive trypsinogen levels. Pediatrics 1990;85(6):1001-7.Parad RB, Comeau AM, Dorkin HL et al. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 2005;147(3 Suppl):S69-72Parad RB, Comeau AM, Dorkin HL et al. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 2005;147(3 Suppl):S69-72Wilcken B. Newborn screening for cystic fibrosis: techniques and strategies. J Inherit Metab Dis. 2007 Aug;30(4):537-43.Wilcken B. Newborn screening for cystic fibrosis: techniques and strategies. J Inherit Metab Dis. 2007 Aug;30(4):537-43.Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus // Journal of Cystic Fibrosis 4 (2005) 7 – 26.Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus // Journal of Cystic Fibrosis 4 (2005) 7 – 26.Bush A., Gotz M. Cystic fibrosis// Chapter 15, p. 234-289 In Eur Resp Mon, 2006; 37.Bush A., Gotz M. Cystic fibrosis// Chapter 15, p. 234-289 In Eur Resp Mon, 2006; 37.Verhaeghe C, Delbecque K, de Leval L, et al. Early inflammation in the airways of a cystic fibrosis foetus // J Cyst Fibros. 2007 Jul;6(4):304-8.Verhaeghe C, Delbecque K, de Leval L, et al. Early inflammation in the airways of a cystic fibrosis foetus // J Cyst Fibros. 2007 Jul;6(4):304-8.Sanders NN, Franckx H, De Boeck K, et al. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis // Thorax. 2006 Nov;61(11):962-8.Sanders NN, Franckx H, De Boeck K, et al. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis // Thorax. 2006 Nov;61(11):962-8.Smyth A, Elborn J. Exacerbations in cystic fibrosis: 3. Management// Thorax.2008; 63: 180-184.Smyth A, Elborn J. Exacerbations in cystic fibrosis: 3. Management// Thorax.2008; 63: 180-184.Koscik RL, Lai HJ, Laxova A. et al. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J.Pediatr 2005;147(3 Suppl):S51-6.Koscik RL, Lai HJ, Laxova A. et al. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J.Pediatr 2005;147(3 Suppl):S51-6.

The authors declare that there are no conflicts of interest present.